See also this year's filing and all EDGAR filings for this company.
PDF Report 0001597264_2023_Blueprint_Medicines_Corp.pdf
Logs
Graph
Absolute values for 0001597264, Blueprint Medicines Corp
xvar | xval | |
---|---|---|
0 | AssetsCurrent | 1,046,651,000 |
1 | IntangibleAssetsNetIncludingGoodwill | 0 |
2 | PropertyPlantAndEquipmentNet | 33,344,000 |
3 | remainder_Assets | 269,907,000 |
4 | LiabilitiesCurrent | 183,234,000 |
5 | LiabilitiesNoncurrent | 116,714,000 |
6 | remainder_Liabilities | 535,277,000 |
7 | CostOfGoodsAndServicesSold | 17,813,000 |
8 | SellingGeneralAndAdministrativeExpense | 237,374,000 |
9 | ResearchAndDevelopmentExpense | 477,419,000 |
10 | remainder_Expenses | 14,184,000 |
11 | remainder_Revenues | 204,036,000 |
12 | remainder_NetIncome | -14,763,000 |
13 | remainder_ComprehensiveNetIncome | -6,310,000 |
yvar | yval | |
---|---|---|
0 | Assets | 1,349,902,000 |
1 | Liabilities | 835,225,000 |
2 | Expenses | 746,790,000 |
3 | Revenues | 204,036,000 |
4 | StockholdersEquity | 514,677,000 |
5 | NetIncome | -557,517,000 |
6 | ComprehensiveNetIncome | -560,672,000 |
7 | BaseVar | 1,578,513,000 |
8 | EconomicCapitalRatio | 0.297 |